Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The classification "No discrete pharmacological molecular target" is used to describe therapeutic agents that do not function by binding to a specific biological macromolecule, such as a protein receptor, enzyme, or transporter (DrugBank Online). Instead, these agents achieve their clinical utility through broad physical or chemical interactions within the physiological environment. For example, antacids like calcium carbonate work via a simple chemical neutralization of hydrochloric acid in the stomach, while osmotic laxatives like polyethylene glycol utilize osmotic pressure to increase stool water content (StatPearls: Antacids; PubMed: 25569441). Other substances in this category include activated charcoal, which acts as a physical adsorbent for toxins, and surfactants like simethicone that alter the surface tension of gas bubbles. Because these treatments lack a specific molecular "lock-and-key" interaction, their pharmacological profiles are governed by their bulk chemical properties and concentration. This designation is critical for pharmacological databases to categorize drugs that fall outside the traditional receptor-based paradigm of drug action.
Drugs in this category exert therapeutic effects through non-specific physical or chemical processes, such as the direct neutralization of gastric acid, the creation of osmotic gradients to retain intestinal water, or the physical adsorption of toxins (DrugBank Online; StatPearls: Antacids).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No discrete pharmacological molecular target.